LMAT (LeMaitre Vascular) Receipts from Customers

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LMAT LeMaitre Vascular Inc LMAT
95 GF Score
Price $80.98
GF Value $95.62
Valuation Modestly Undervalued
View Full Analysis

What is LeMaitre Vascular Receipts from Customers?

Receipts from Customers only applicable to companies reporting Cash Flow from Operations in direct method.

LMAT
95GF Score
LeMaitre Vascular Inc LMAT
Receipts from Customers is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is LeMaitre Vascular (LMAT) Overvalued in 2026?

Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued. The current stock price of $80.98 is trading 15.3% below its estimated GF Value™ of $95.62. GuruFocus considers LeMaitre Vascular to be Modestly Undervalued.

Key valuation signals for LMAT:

  • Receipts from Customers:
  • GF Value™: $95.62 vs. price of $80.98 (15.3% below fair value)
  • GF Score™: 95/100

No single metric tells the full story. See the LMAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LeMaitre Vascular Business Description

Other Exchanges LHU:Germany
Address 63 Second Avenue, Burlington, MA, USA, 01803
LeMaitre Vascular Inc. is a medical device company that develops, manufactures, and markets vascular devices used primarily by vascular surgeons, and to a lesser extent by cardiac, general, and neurosurgeons. Its portfolio includes branded products for open vascular and endovascular procedures, such as valvulotomes, carotid shunts, biologic patches, vascular grafts, embolectomy catheters, and balloon catheters. The company also provides human tissue cryopreservation services. LeMaitre sells its products to hospitals and clinics through a direct sales force in the United States and select international markets, supplemented by distributors elsewhere. It operates across the Americas, Europe, the Middle East, Africa, and Asia Pacific, with the Americas generating the largest share of revenue. Revenue comes mainly from product sales, with recurring sales driven by consumable and implantable devices used in surgical procedures.
95GF Score

Get the complete analysis for LMAT

Receipts from Customers is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$80.98
Price
$95.62
GF Value